We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FNLC:NASDAQFirst Bancorp, Inc (ME) Analysis

Data as of 2026-09-27 - not real-time

$34.35

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The First Bancorp, Inc. is priced at $34.35, and its moving averages give no clean directional read — the structure is neutral. Across the trailing 30 sessions it lost 3.3%. Momentum indicators put RSI at 44.9 (neutral) with MACD reading bearish. The recent range runs from support at $33.65 up to resistance at $35.83.
On valuation the read is undervalued — earnings multiple of 10.2 versus a 15.6 sector average, below the peer group. Revenue is growing at 12.9% on a 38.3% profit margin. The 4.43% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 18.0%, a beta of 0.24 and a maximum drawdown of 10.4%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 6/10 conviction on the long call.

Top Market Events

First Bancorp stock trades in a narrow range on the Nasdaq Capital Market as of September 18, 2026,First Bancorp stock closed at USD 27.77 on September 18, 2026, with a recent 16.9 percent weekly gaiMarketScreener3dThe First Bancorp Declares Third Quarter DividendThe First Bancorp NASDAQ: FNLC , the parent company of...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 30.46
  • MACD momentum is negative
  • RSI at 44.9 is in neutral territory

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 10.2 versus sector average of 15.6
  • Trading above the 200-day average of 30.46
  • MACD momentum is negative

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 10.2 versus sector average of 15.6
  • Profit margin of 38.3% is healthy
  • Revenue growth of +12.9%

Key Metrics & Analysis

Financial Health

Revenue Growth12.90%
Profit Margin38.26%
P/E Ratio10.2
ROE13.54%
ROA1.18%
P/B Ratio1.3
Op. Cash Flow$38.1M
Industry P/E15.6

Technical Analysis

TrendNeutral
RSI44.9
Support$33.65
Resistance$35.83
MA 20$34.78
MA 50$34.91
MA 200$30.46
MACDBearish
VolumeIncreasing
Fear & Greed Index94.88

Valuation

Fair Value$32.31
GradeUndervalued
TypeValue
Dividend Yield4.43%

Risk Assessment

Beta0.24
Volatility17.97%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.